Internal Medicine, Sleep Medicine · Sylvania, OH
NPI
1013915263
Since 2005
Specialty
Internal Medicine, Sleep Medicine
Code 207RS0012X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
7135 Sylvania Ave Ste 2
Sylvania, OH, 43560
Phone (419) 479-5392
Groups this clinician bills Medicare through
Medicare paid, 2024
$205K
2,607 services
Medicare patients, 2024
571
Average age 73
Drug cost, 2024
$1.6M
4,331 prescriptions
Company payments, 2025
$2,867
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Naeem A Lughmani was code 99214 (office e&m - established), 736 times for 348 patients. In total Naeem A Lughmani billed 2,607 services in 18 codes, and Medicare paid $205K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 736 | 348 | $85.07 | $63K |
| 94727 Pulmonary Function Testing | Office | 349 | 285 | $29.00 | $10K |
| 94729 Pulmonary Function Testing | Office | 342 | 282 | $37.71 | $13K |
| 94060 Pulmonary Function Testing | Office | 335 | 277 | $26.09 | $8,740 |
| 95811 Sleep Study | Office | 113 | 102 | $452.61 | $51K |
| 95811 Sleep Study | Facility | 105 | 96 | $88.31 | $9,272 |
| 94729 Pulmonary Function Testing | Facility | 91 | 87 | $5.98 | $544 |
| 99204 Office E&M - New | Office | 83 | 83 | $105.02 | $8,716 |
| 94060 Pulmonary Function Testing | Facility | 82 | 79 | $7.00 | $574 |
| 99213 Office E&M - Established | Office | 77 | 68 | $55.65 | $4,285 |
| 94727 Pulmonary Function Testing | Facility | 62 | 59 | $8.22 | $510 |
| 95810 Sleep Study | Office | 54 | 52 | $440.51 | $24K |
| 95810 Sleep Study | Facility | 46 | 44 | $80.70 | $3,712 |
| 94726 Pulmonary Function Testing | Facility | 25 | 24 | $7.87 | $197 |
| 99215 Office E&M - Established | Office | 24 | 20 | $135.78 | $3,259 |
By year: 2022 $229K for 2,658 services; 2023 $227K for 2,552 services; 2024 $205K for 2,607 services.
Medicare prescription drug claims, 2024
In 2024, the drug Naeem A Lughmani prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 552 prescriptions and refills. In total Naeem A Lughmani wrote 4,331 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 552 | 719 | 129 | $453K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 545 | 615 | 224 | $14K |
| Trazodone Hcl Generic | 216 | 318 | 63 | $969 |
| Breo Ellipta Fluticasone/Vilanterol | 207 | 268 | 71 | $103K |
| Montelukast Sodium Generic | 199 | 361 | 47 | $1,296 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 196 | 313 | 44 | $1,581 |
| Zolpidem Tartrate Generic | 175 | 203 | 63 | $1,235 |
| Omeprazole Generic | 138 | 202 | 28 | $725 |
| Armodafinil Generic | 134 | 168 | 25 | $9,180 |
| Roflumilast Generic | 125 | 151 | 34 | $9,750 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 124 | 163 | 42 | $99K |
| Fluticasone Propionate Generic | 122 | 186 | 57 | $4,802 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 102 | 126 | 31 | $10K |
| Modafinil Generic | 99 | 134 | 32 | $7,604 |
| Spiriva Respimat Tiotropium Bromide | 94 | 120 | 29 | $61K |
Brand drugs: 1,845 claims; generic drugs: 2,486 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naeem A Lughmani $2,867 ($2,867 in general payments such as food, travel and fees) from 17 companies. The largest payer was Harmony Biosciences LLC with $686.
| Company | Payments | Amount |
|---|---|---|
| Harmony Biosciences LLC HRMY | 23 | $686 |
| Axsome Therapeutics, Inc. AXSM | 37 | $332 |
| Avadel CNS Pharmaceuticals, LLC | 17 | $313 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $284 |
| GlaxoSmithKline, LLC. GSK | 19 | $252 |
| Jazz Pharmaceuticals Inc. JAZZ | 7 | $169 |
| Genzyme Corporation SNY | 9 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $140 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $94.86 |
| Amgen Inc. AMGN | 5 | $91.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.